|
Why
Partner with AH? >> Product Development Focus
The
Company has had significant success in developing probiotic
technologies for the Management of inflammatory and infectious
conditions. In order to continue as a leading player in
probiotic and pharmabiotic technologies, the Company will
advance its programmes through rigorous scientific and
clinical validation.
The
company plans to have products available in three product
marketing areas:
- Rx
(Prescription) Pharmaceutical Products – For products
with near term launch horizons, the company intends
to focus the majority of its resources to progressing
these products to market. These may be progressed
solely by AH or in partnership. For longer term products,
AH intends to continue development of early stage
leads for commercial out-licensing at the appropriate
phase of development.
- Clinical
Nutrition Products – The company intends to continue
to pursue applications of its technology in the clinical
nutrition area focussing on products for the elderly
and infirm.
- OTC
products -
The continued launch of a range of clinically proven
products in the OTC market through its established
“Blue Chip” commercial partnerships provides the company
with validation and market acceptance of its technologies.
|
